Repligen
RGEN
#2039
Rank
S$12.09 B
Marketcap
S$214.78
Share price
-0.46%
Change (1 day)
7.22%
Change (1 year)
Categories

Repligen (RGEN) - Net assets

Net assets on the balance sheet as of September 2025 : S$2.69 Billion

According to Repligen 's latest financial reports the company has S$2.69 Billion in net assets.
A companyโ€™s net assets is the sum of its assets minus the sum of its liabilities.

Repligen - Net assets on balance sheet (from 2001 to 2025)

Net assets by year

Year Net assets Change
2024-12-31$S$2.68 B3.33%
2023-12-31$S$2.59 B1.31%
2022-12-31$S$2.56 B8.27%
2021-12-31$S$2.36 B16.95%
2020-12-31$S$2.02 B41.59%
2019-12-31$S$1.42 B69.9%
2018-12-31$S$0.84 B6.29%
2017-12-31$S$0.79 B223.93%
2016-12-31$S$0.24 B40.67%
2015-12-31$S$0.17 B17.61%
2014-12-31$S$0.14 B12.17%
2013-12-31$S$0.13 B27.94%
2012-12-31$S$0.10 B
2011-03-31$S$84.53 M-8.5%
2010-03-31$S$92.39 M-12.01%
2009-03-31$S$0.10 B18.75%
2008-03-31$S$88.41 M128.2%
2007-03-31$S$38.74 M-6.39%
2006-03-31$S$41.38 M2.75%
2005-03-31$S$40.28 M-11.24%
2004-03-31$S$45.38 M4.69%
2003-03-31$S$43.35 M-11.21%
2002-03-31$S$48.82 M-12.93%
2001-03-31$S$56.07 M

Net assets for similar companies or competitors

Company Net assets differencediff. Country
Novavax
NVAX
-S$0.21 Billion-107.52%๐Ÿ‡บ๐Ÿ‡ธ USA
BioMarin Pharmaceutical
BMRN
S$7.84 B 190.76%๐Ÿ‡บ๐Ÿ‡ธ USA
Neurocrine Biosciences
NBIX
S$3.89 B 44.19%๐Ÿ‡บ๐Ÿ‡ธ USA
General Electric
GE
S$24.64 B 813.11%๐Ÿ‡บ๐Ÿ‡ธ USA
Thermo Fisher Scientific
TMO
S$66.28 B 2,355.68%๐Ÿ‡บ๐Ÿ‡ธ USA
Bristol-Myers Squibb
BMY
S$24.10 B 792.90%๐Ÿ‡บ๐Ÿ‡ธ USA
Pfizer
PFE
S$120.62 B 4,369.13%๐Ÿ‡บ๐Ÿ‡ธ USA
Bio-Techne
TECH
S$2.54 B-5.63%๐Ÿ‡บ๐Ÿ‡ธ USA
Sangamo Therapeutics
SGMO
S$8.08 M-99.70%๐Ÿ‡บ๐Ÿ‡ธ USA
Charles River Laboratories
CRL
S$4.47 B 65.66%๐Ÿ‡บ๐Ÿ‡ธ USA